ArticleNeurochemical research2016

The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.

Alicia Gutnisky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.